Jake Jaesang Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jake Jaesang Lee has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
Dorina Kallogjeri
Clinical Outcomes Research Office, Department of Otolaryngology–Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri
10 shared publicationsJohn S. Schneider
Department of Otolaryngology–Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri
9 shared publicationsJay F. Piccirillo
Clinical Outcomes Research Office, Department of Otolaryngology–Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri
8 shared publicationsPatrik Pipkorn
Department of Otolaryngology—Head and Neck Surgery Washington University School of Medicine in St. Louis St Louis Missouri USA
8 shared publicationsCristine N. Klatt-Cromwell
Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
5 shared publications- Patrik Pipkorn
Washington University in St. Louis 7 St Louis
5 shared publications
Latest Publications
- 25 June 2025
- Published by Wiley in Head & Neck
- Vol. 47 (11) , 3058-3067
Predictors and Implications of Bony Union of Osseous Free Flaps for Oromandibular Reconstruction
Background: Optimal contouring of osseous free flaps for mandibulectomy often requires osteotomies. The impact of malunion or nonunion on hardware extrusion is not well‐documented. This study assesses postoperative bony union, its correlation with plate extrusion, and related demographic and surgical predictors. Methods: A retrospective study of 127 patients who underwent segmental mandibulectomy and osseous free tissue transfer from 2004 to 2019. Bony union was assessed via computed tomography (CT) scans at 6–9, 9–15, and 15–24 months using a callus scale. Logistic regression analyzed the relationship between bony union, hardware extrusion, and various factors. Results: Radiographic nonunion rates at 6–9, 9–15, and 15–24 months were 24.8%, 20.4%, and 13.2%, respectively. Nonunion at 9–15 months (OR = 3.67) and 15–24 months (OR = 1.80) significantly increased hardware extrusion risk. Lower bony union was linked to prior radiation, alcohol use, perioperative complications, and thinner plates. Conclusions: Bone union after oromandibular free‐flap reconstruction is affected by radiation, perioperative complications, and smoking. Fibular and scapular transfers had similar outcomes. Further long‐term studies are needed to enhance reconstruction techniques.
- 25 June 2025
- Published by Wiley in Head & Neck
- Vol. 47 (11) , 3058-3067
Predictors and Implications of Bony Union of Osseous Free Flaps for Oromandibular Reconstruction
Background: Optimal contouring of osseous free flaps for mandibulectomy often requires osteotomies. The impact of malunion or nonunion on hardware extrusion is not well‐documented. This study assesses postoperative bony union, its correlation with plate extrusion, and related demographic and surgical predictors. Methods: A retrospective study of 127 patients who underwent segmental mandibulectomy and osseous free tissue transfer from 2004 to 2019. Bony union was assessed via computed tomography (CT) scans at 6–9, 9–15, and 15–24 months using a callus scale. Logistic regression analyzed the relationship between bony union, hardware extrusion, and various factors. Results: Radiographic nonunion rates at 6–9, 9–15, and 15–24 months were 24.8%, 20.4%, and 13.2%, respectively. Nonunion at 9–15 months (OR = 3.67) and 15–24 months (OR = 1.80) significantly increased hardware extrusion risk. Lower bony union was linked to prior radiation, alcohol use, perioperative complications, and thinner plates. Conclusions: Bone union after oromandibular free‐flap reconstruction is affected by radiation, perioperative complications, and smoking. Fibular and scapular transfers had similar outcomes. Further long‐term studies are needed to enhance reconstruction techniques.
- Open Access
- 27 February 2024
- Published by Wiley in Head & Neck
- Vol. 46 (5) , 1020-1027
Airway protection and outcomes after staged versus concurrent bilateral neck dissections with transoral base of tongue cancer resection
Objectives: To assess airway, safety, and resource utilization outcomes between transoral base of tongue (BOT) surgery with staged versus concurrent bilateral neck dissections (BND).Methods: A retrospective cohort study of patients with human papilloma virus (HPV)‐related BOT cancer who underwent transoral surgery and BND from January 2015 through June 2022 was conducted. Free flap patients were excluded.Results: Of 126 patients (46 [37%] staged and 80 [63%] concurrent BND), there were no significant differences in rates of postoperative intubation, tracheostomy, intensive care admission, operative takebacks, gastrostomy, and 30‐day readmission. Total operative time (median difference 1.4 [95% CI 0.9–1.8] hours), length of stay (1.0 [1.0–1.0] day), and time between primary surgery and adjuvant therapy initiation (4.0 [0.0–8.0] days) were lower in the concurrent BND cohort.Conclusion: Concurrent BND alongside transoral BOT resection is safe with similar airway outcomes and lower total operative time, length of stay, and time to adjuvant therapy initiation compared to staged BND.
- 27 February 2024
- Published by Wiley in Head & Neck
- Vol. 46 (5) , 1020-1027
Open AccessAirway protection and outcomes after staged versus concurrent bilateral neck dissections with transoral base of tongue cancer resection
Objectives: To assess airway, safety, and resource utilization outcomes between transoral base of tongue (BOT) surgery with staged versus concurrent bilateral neck dissections (BND).Methods: A retrospective cohort study of patients with human papilloma virus (HPV)‐related BOT cancer who underwent transoral surgery and BND from January 2015 through June 2022 was conducted. Free flap patients were excluded.Results: Of 126 patients (46 [37%] staged and 80 [63%] concurrent BND), there were no significant differences in rates of postoperative intubation, tracheostomy, intensive care admission, operative takebacks, gastrostomy, and 30‐day readmission. Total operative time (median difference 1.4 [95% CI 0.9–1.8] hours), length of stay (1.0 [1.0–1.0] day), and time between primary surgery and adjuvant therapy initiation (4.0 [0.0–8.0] days) were lower in the concurrent BND cohort.Conclusion: Concurrent BND alongside transoral BOT resection is safe with similar airway outcomes and lower total operative time, length of stay, and time to adjuvant therapy initiation compared to staged BND.
- 1 December 2022
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 148 (12) , 1132-1138
Development and Psychometric Validation of the Olfactory Dysfunction Outcomes Rating
Importance: Olfactory dysfunction (OD) is an increasingly common and morbid condition, especially given the ongoing COVID-19 pandemic. Thus, the ability to reproducibly measure smell loss–associated quality of life (QOL) and its response to treatment is paramount.Objective: To develop and validate a concise and visually appealing smell loss–associated QOL patient-reported outcome measure for OD.Design, Setting, and Participants: A secondary analysis of comments to an online survey by 1000 patients with olfactory dysfunction published in 2013 was used as the primary source to generate items of the Olfactory Dysfunction Outcomes Rating (ODOR). In addition, 30 patients with OD enrolled in 2 clinical studies at a tertiary care medical center (Washington University) were asked to identify their main concerns associated with smell loss. And finally, 4 otolaryngologists reviewed the items generated from the online survey and the patients’ interviews to identify any additional items. Prospective study design was used for data collection from the 30 patients and 4 otolaryngologists. Prospective study design was used for survey validation. Validation of the ODOR was performed with 283 patients enrolled in several prospective studies at a single institution that completed the ODOR as an outcome measure.Main Outcomes and Measures: Item generation and selection were the outcomes of ODOR development. The psychometric and clinimetric measures evaluated for validation were internal consistency, test-retest reliability, face and content validity, concurrent validity, and discriminant validity. Minimal clinically important difference was also determined.Results: The ODOR is a 28-item instrument with each item scored as either no difficulty or very rarely bothered (0) to complete difficulty or very frequently bothered (4) with a total instrument score range of 0 to 112 points. Higher scores indicate higher degree of dysfunction and limitation. Validation in the cohort of 283 patients (mean [SD] age, 47.0 [14.4] years; 198 female participants [73%]; 179 White participants [80%]) revealed that the instrument has high internal consistency (Cronbach α = 0.968), test-retest reliability (r = 0.90 [95% CI, 0.81-0.95]), face validity, content validity, concurrent validity (r = 0.87 [95% CI, 0.80-0.91] compared with the Questionnaire of Olfactory Disorders–Negative Statements; ρ = −0.76 [95% CI, −0.81 to −0.71] compared with a patient-reported symptom severity scale), and divergent validity (mean score difference, −33.9 [95% CI, −38.3 to −29.6] between normosmic patients and hyposmic/anosmic patients). The minimal clinically important difference was 15 points. The estimated time for survey completion was approximately 5 minutes.Conclusions and Relevance: In this survey creation and validation study, the ODOR was shown to be a novel, concise, reliable, and valid patient-reported outcome measure of OD-associated QOL. It can be used to measure physical problems, functional limitations, and emotional consequences associated with OD and how they change after a given intervention, which is clinically applicable and particularly pertinent given the growing burden of OD associated with COVID-19.
- 1 December 2022
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 148 (12) , 1132-1138
Development and Psychometric Validation of the Olfactory Dysfunction Outcomes Rating
Importance: Olfactory dysfunction (OD) is an increasingly common and morbid condition, especially given the ongoing COVID-19 pandemic. Thus, the ability to reproducibly measure smell loss–associated quality of life (QOL) and its response to treatment is paramount.Objective: To develop and validate a concise and visually appealing smell loss–associated QOL patient-reported outcome measure for OD.Design, Setting, and Participants: A secondary analysis of comments to an online survey by 1000 patients with olfactory dysfunction published in 2013 was used as the primary source to generate items of the Olfactory Dysfunction Outcomes Rating (ODOR). In addition, 30 patients with OD enrolled in 2 clinical studies at a tertiary care medical center (Washington University) were asked to identify their main concerns associated with smell loss. And finally, 4 otolaryngologists reviewed the items generated from the online survey and the patients’ interviews to identify any additional items. Prospective study design was used for data collection from the 30 patients and 4 otolaryngologists. Prospective study design was used for survey validation. Validation of the ODOR was performed with 283 patients enrolled in several prospective studies at a single institution that completed the ODOR as an outcome measure.Main Outcomes and Measures: Item generation and selection were the outcomes of ODOR development. The psychometric and clinimetric measures evaluated for validation were internal consistency, test-retest reliability, face and content validity, concurrent validity, and discriminant validity. Minimal clinically important difference was also determined.Results: The ODOR is a 28-item instrument with each item scored as either no difficulty or very rarely bothered (0) to complete difficulty or very frequently bothered (4) with a total instrument score range of 0 to 112 points. Higher scores indicate higher degree of dysfunction and limitation. Validation in the cohort of 283 patients (mean [SD] age, 47.0 [14.4] years; 198 female participants [73%]; 179 White participants [80%]) revealed that the instrument has high internal consistency (Cronbach α = 0.968), test-retest reliability (r = 0.90 [95% CI, 0.81-0.95]), face validity, content validity, concurrent validity (r = 0.87 [95% CI, 0.80-0.91] compared with the Questionnaire of Olfactory Disorders–Negative Statements; ρ = −0.76 [95% CI, −0.81 to −0.71] compared with a patient-reported symptom severity scale), and divergent validity (mean score difference, −33.9 [95% CI, −38.3 to −29.6] between normosmic patients and hyposmic/anosmic patients). The minimal clinically important difference was 15 points. The estimated time for survey completion was approximately 5 minutes.Conclusions and Relevance: In this survey creation and validation study, the ODOR was shown to be a novel, concise, reliable, and valid patient-reported outcome measure of OD-associated QOL. It can be used to measure physical problems, functional limitations, and emotional consequences associated with OD and how they change after a given intervention, which is clinically applicable and particularly pertinent given the growing burden of OD associated with COVID-19.
- Open Access
- 1 September 2022
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 148 (9) , 885-886
Safety of High-Dose Nasal Theophylline Irrigation in the Treatment of Postviral Olfactory Dysfunction: A Dose-Escalation Study
Olfactory dysfunction (OD) is an increasingly prevalent and debilitating condition associated with acute and chronic SARS-CoV-2 infection.1 Despite the rise in postviral OD (PVOD), to our knowledge, no universally effective treatments exist.2 Theophylline is a potential, newer treatment for OD.3 We recently completed a double-blind, placebo-controlled randomized clinical trial (RCT) of patients who received 6 weeks of nasal theophylline irrigation (12 mg twice daily) vs placebo saline irrigation.4 The study found no clinically meaningful differences in olfaction, but the theophylline was likely underdosed.
- 1 September 2022
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 148 (9) , 885-886
Open AccessSafety of High-Dose Nasal Theophylline Irrigation in the Treatment of Postviral Olfactory Dysfunction: A Dose-Escalation Study
Olfactory dysfunction (OD) is an increasingly prevalent and debilitating condition associated with acute and chronic SARS-CoV-2 infection.1 Despite the rise in postviral OD (PVOD), to our knowledge, no universally effective treatments exist.2 Theophylline is a potential, newer treatment for OD.3 We recently completed a double-blind, placebo-controlled randomized clinical trial (RCT) of patients who received 6 weeks of nasal theophylline irrigation (12 mg twice daily) vs placebo saline irrigation.4 The study found no clinically meaningful differences in olfaction, but the theophylline was likely underdosed.
- 25 May 2022
- Published by Wiley in The Laryngoscope
- Vol. 133 (3) , 594-600
Risk Factors for Functional Outcomes in Advanced Laryngeal Squamous Cell Carcinoma
Objective: Chemoradiation for patients with laryngeal squamous cell carcinoma (SCC) may achieve organ preservation, but appropriate patient selection remains unknown. This study investigates pre‐treatment risk factors associated with functional and survival outcomes after radiation‐based therapy in patients with advanced laryngeal SCC.Methods: A retrospective cohort study was performed on 75 adult patients with stage III or IV laryngeal SCC receiving definitive radiation‐based therapy from 1997 to 2016 at a tertiary care center. Tracheostomy and gastrostomy dependence were the primary functional outcomes. Multivariable logistic regressions were performed to evaluate relationships between pre‐treatment factors and tracheostomy and gastrostomy dependence. Time‐to‐event analyses were performed to determine risk factors associated with overall survival.Results: Among 75 patients included in the analysis, 30 (40%) patients were tracheostomy dependent and 31 (41%) were gastrostomy tube dependent. The median length of follow‐up was 31 months (range = 1 to 142 months). Pre‐treatment tracheostomy was a significant predictor of post‐treatment tracheostomy (aOR = 13.9, 95% CI = 3.35 to 57.5) and moderate–severe comorbidity was a significant predictor of post‐treatment gastrostomy dependence (aOR = 2.96, 95% CI = 1.04 to 8.43). The five‐year overall survival was 51% (95% CI = 38 to 64%). Pre‐treatment gastrostomy tube dependence was associated with an increased risk of death (aHR = 2.45, 95% CI = 1.09 to 5.53).Conclusions: Baseline laryngeal functional status and overall health in advanced laryngeal SCC are associated with poor functional outcomes after radiation‐based therapy, highlighting the importance of patient selection when deciding between surgical and non‐surgical treatment plans. Laryngoscope, 133:594–600, 2023
- 25 May 2022
- Published by Wiley in The Laryngoscope
- Vol. 133 (3) , 594-600
Risk Factors for Functional Outcomes in Advanced Laryngeal Squamous Cell Carcinoma
Objective: Chemoradiation for patients with laryngeal squamous cell carcinoma (SCC) may achieve organ preservation, but appropriate patient selection remains unknown. This study investigates pre‐treatment risk factors associated with functional and survival outcomes after radiation‐based therapy in patients with advanced laryngeal SCC.Methods: A retrospective cohort study was performed on 75 adult patients with stage III or IV laryngeal SCC receiving definitive radiation‐based therapy from 1997 to 2016 at a tertiary care center. Tracheostomy and gastrostomy dependence were the primary functional outcomes. Multivariable logistic regressions were performed to evaluate relationships between pre‐treatment factors and tracheostomy and gastrostomy dependence. Time‐to‐event analyses were performed to determine risk factors associated with overall survival.Results: Among 75 patients included in the analysis, 30 (40%) patients were tracheostomy dependent and 31 (41%) were gastrostomy tube dependent. The median length of follow‐up was 31 months (range = 1 to 142 months). Pre‐treatment tracheostomy was a significant predictor of post‐treatment tracheostomy (aOR = 13.9, 95% CI = 3.35 to 57.5) and moderate–severe comorbidity was a significant predictor of post‐treatment gastrostomy dependence (aOR = 2.96, 95% CI = 1.04 to 8.43). The five‐year overall survival was 51% (95% CI = 38 to 64%). Pre‐treatment gastrostomy tube dependence was associated with an increased risk of death (aHR = 2.45, 95% CI = 1.09 to 5.53).Conclusions: Baseline laryngeal functional status and overall health in advanced laryngeal SCC are associated with poor functional outcomes after radiation‐based therapy, highlighting the importance of patient selection when deciding between surgical and non‐surgical treatment plans. Laryngoscope, 133:594–600, 2023
- 24 May 2022
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 168 (3) , 261-268
Infection Control With Topical Antimicrobial Prophylaxis for Mucosal Head and Neck Surgery: A Meta‐analysis
Objective: To assess for differences in surgical site infection (SSI) rates and bacterial load after major mucosal head and neck surgery between patients who received topical antimicrobial prophylaxis and those who did not.Data Sources: Ovid Medline, Embase, SCOPUS, Cochrane Library, and ClinicalTrials.gov from inception to May 20, 2021, with cross‐referencing of retrieved studies per PRISMA guidelines.Review Methods: Inclusion criteria captured clinical trials, cohort studies, and case‐control studies with infectious outcomes of adults who underwent major mucosal head and neck surgery and received perioperative topical antimicrobial therapy to the oral cavity and/or pharynx. Studies of dental procedures were excluded. The primary outcome was SSI rate, and the secondary outcome was bacterial load. Two blinded investigators screened each text.Results: Of 265 unique citations, 9 studies of 470 total patients were included. Topical treatments included numerous antibiotics and antiseptics directly applied over mucosa. Pooled SSI rates of 252 patients in the intervention cohort and 218 in the control cohort were 8% (95% CI, 3%‐14%; I 2 = 61.2%) and 29% (95% CI, 16%‐43%; I 2 = 79.5%), respectively. A meta‐analysis of 7 comparative studies totaling 192 patients receiving topical therapy and 218 control patients revealed a pooled relative risk of 0.44 (95% CI, 0.28‐0.68; I 2 = 0.0%) in favor of the treatment group. The studies demonstrated a short‐term decrease in bacterial counts after topical antimicrobial prophylaxis.Conclusion: Patients who underwent prophylactic topical antimicrobial therapy had less than half the risk of developing SSI after mucosal head and neck surgery when compared with those who received no topical prophylaxis.
- 24 May 2022
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 168 (3) , 261-268
Infection Control With Topical Antimicrobial Prophylaxis for Mucosal Head and Neck Surgery: A Meta‐analysis
Objective: To assess for differences in surgical site infection (SSI) rates and bacterial load after major mucosal head and neck surgery between patients who received topical antimicrobial prophylaxis and those who did not.Data Sources: Ovid Medline, Embase, SCOPUS, Cochrane Library, and ClinicalTrials.gov from inception to May 20, 2021, with cross‐referencing of retrieved studies per PRISMA guidelines.Review Methods: Inclusion criteria captured clinical trials, cohort studies, and case‐control studies with infectious outcomes of adults who underwent major mucosal head and neck surgery and received perioperative topical antimicrobial therapy to the oral cavity and/or pharynx. Studies of dental procedures were excluded. The primary outcome was SSI rate, and the secondary outcome was bacterial load. Two blinded investigators screened each text.Results: Of 265 unique citations, 9 studies of 470 total patients were included. Topical treatments included numerous antibiotics and antiseptics directly applied over mucosa. Pooled SSI rates of 252 patients in the intervention cohort and 218 in the control cohort were 8% (95% CI, 3%‐14%; I 2 = 61.2%) and 29% (95% CI, 16%‐43%; I 2 = 79.5%), respectively. A meta‐analysis of 7 comparative studies totaling 192 patients receiving topical therapy and 218 control patients revealed a pooled relative risk of 0.44 (95% CI, 0.28‐0.68; I 2 = 0.0%) in favor of the treatment group. The studies demonstrated a short‐term decrease in bacterial counts after topical antimicrobial prophylaxis.Conclusion: Patients who underwent prophylactic topical antimicrobial therapy had less than half the risk of developing SSI after mucosal head and neck surgery when compared with those who received no topical prophylaxis.
- 2 April 2022
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 132 (2) , 226-232
Eight Tales of Cervical Necrotizing Fasciitis and Free Tissue Transfer
Objectives: Aggressive surgical debridement is required in cervical necrotizing fasciitis, and in severe defects, subsequent free tissue transfer might be necessary. However, there is concern that the inflammatory environment of the infection site may threaten free flap viability, particularly with concerns for thrombosis of feeding vessels and compromised tissue integration. Cases in the head and neck area are rare, so there are limited data regarding outcomes of free tissue transfer in these patients. Methods: A retrospective chart review assessed patients with cervical necrotizing fasciitis treated at an academic tertiary hospital between 2015 and 2021. Twenty-five patients were identified, and eight required free tissue transfer after adequate surgical debridement. Treatment, hospital course, and demographic data were collected on these eight patients. Results: All flaps had full survival at follow up (median follow up 3 months, range 1-39 months) without concerns for vascular compromise. Conclusion: These data suggest that in patients with large soft tissue defects due to cervical necrotizing fasciitis, free tissue transfer may be a safe treatment modality.
- 2 April 2022
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 132 (2) , 226-232
Eight Tales of Cervical Necrotizing Fasciitis and Free Tissue Transfer
Objectives: Aggressive surgical debridement is required in cervical necrotizing fasciitis, and in severe defects, subsequent free tissue transfer might be necessary. However, there is concern that the inflammatory environment of the infection site may threaten free flap viability, particularly with concerns for thrombosis of feeding vessels and compromised tissue integration. Cases in the head and neck area are rare, so there are limited data regarding outcomes of free tissue transfer in these patients. Methods: A retrospective chart review assessed patients with cervical necrotizing fasciitis treated at an academic tertiary hospital between 2015 and 2021. Twenty-five patients were identified, and eight required free tissue transfer after adequate surgical debridement. Treatment, hospital course, and demographic data were collected on these eight patients. Results: All flaps had full survival at follow up (median follow up 3 months, range 1-39 months) without concerns for vascular compromise. Conclusion: These data suggest that in patients with large soft tissue defects due to cervical necrotizing fasciitis, free tissue transfer may be a safe treatment modality.
- 3 December 2021
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 43 (2) , 103299
Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction
- 3 December 2021
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 43 (2) , 103299
Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction
- 1 September 2021
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 43 (1) , 103188
Chronic rhinosinusitis as a risk factor for intracranial and extracranial complications after endoscopic transsphenoidal surgery
- 1 September 2021
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 43 (1) , 103188
Chronic rhinosinusitis as a risk factor for intracranial and extracranial complications after endoscopic transsphenoidal surgery
- 23 August 2021
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 21 (6) , 478-484
Endonasal Free Flap Reconstruction Combined With Draf Frontal Sinusotomy for Complex Cerebrospinal Fluid Leak: A Technical Report & Case Series
BACKGROUND: Frontal sinus cranialization with closure via bifrontal pericranial flaps is the gold standard for separating the nasofrontal recess from the intracranial cavity for posterior table defects. Despite the high success rate, cerebrospinal fluid (CSF) leak may persist and is particularly challenging when vascularized reconstructive options from the bicoronal incision are exhausted. OBJECTIVE: To assess a novel endonasal technique using an adipofascial radial forearm free flap delivered to the frontal recess through a Draf sinusotomy to repair complex CSF leaks from the frontal sinus. METHODS: A retrospective review of 3 patients (all male; ages 42, 43, and 69 yr) with persistent CSF leak despite frontal sinus cranialization and repair with bifrontal pericranium was performed. Etiology of injury was traumatic in 2 patients and iatrogenic in 1 patient after anaplastic meningioma treatment. To create space for the flap and repair the nasofrontal ducts, endoscopic Draf III (Case 1, 3) or Draf IIb left frontal sinusotomy (Case 2) was performed. The forearm flap was harvested, passed through a Caldwell-Luc exposure, and placed within the Draf frontal sinustomy. The flap vessels were tunneled to the left neck and anastomosed to the facial vessels by the mandibular notch. RESULTS: Intraoperatively, the flaps were well-seated and provided a watertight seal. Postoperative hospital courses were uncomplicated. There were no new CSF leaks or flap necrosis at 12, 14, and 16 mo. CONCLUSION: Endoscopic endonasal free flap reconstruction through a Draf procedure is a novel viable option for persistent CSF leak after failed frontal sinus cranialization.
- 23 August 2021
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 21 (6) , 478-484
Endonasal Free Flap Reconstruction Combined With Draf Frontal Sinusotomy for Complex Cerebrospinal Fluid Leak: A Technical Report & Case Series
BACKGROUND: Frontal sinus cranialization with closure via bifrontal pericranial flaps is the gold standard for separating the nasofrontal recess from the intracranial cavity for posterior table defects. Despite the high success rate, cerebrospinal fluid (CSF) leak may persist and is particularly challenging when vascularized reconstructive options from the bicoronal incision are exhausted. OBJECTIVE: To assess a novel endonasal technique using an adipofascial radial forearm free flap delivered to the frontal recess through a Draf sinusotomy to repair complex CSF leaks from the frontal sinus. METHODS: A retrospective review of 3 patients (all male; ages 42, 43, and 69 yr) with persistent CSF leak despite frontal sinus cranialization and repair with bifrontal pericranium was performed. Etiology of injury was traumatic in 2 patients and iatrogenic in 1 patient after anaplastic meningioma treatment. To create space for the flap and repair the nasofrontal ducts, endoscopic Draf III (Case 1, 3) or Draf IIb left frontal sinusotomy (Case 2) was performed. The forearm flap was harvested, passed through a Caldwell-Luc exposure, and placed within the Draf frontal sinustomy. The flap vessels were tunneled to the left neck and anastomosed to the facial vessels by the mandibular notch. RESULTS: Intraoperatively, the flaps were well-seated and provided a watertight seal. Postoperative hospital courses were uncomplicated. There were no new CSF leaks or flap necrosis at 12, 14, and 16 mo. CONCLUSION: Endoscopic endonasal free flap reconstruction through a Draf procedure is a novel viable option for persistent CSF leak after failed frontal sinus cranialization.